AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia

NCT00180128 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Promyelocytic, Acute

Interventions

DRUG: all-trans retinoid acid
DRUG: idarubicin
DRUG: mitoxantrone
DRUG: daunorubicin
DRUG: cytarabine

Sponsor

Technische Universität Dresden